Trifunctional Bispecific Antibodies Induce Tumor-Specific T Cells and Elicit a Vaccination Effect
Nina Eissler, Peter Ruf, Josef Mysliwietz, Horst Lindhofer, and Ralph Mocikat Pr ecis: T-cell-activating signals that can be triggered by trifunctional bispecific antibodies make them superior for eliminating tumor cells due to their ability to induce polyvalent protective T-cell responses against tumor-derived peptides.
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